Buy Enhertu (Trastuzumab + Deruxtecan) Injection Online from GlobMedIndia India.

Enhertu (Trastuzumab + Deruxtecan) Injection

Introduction

Enhertu (trastuzumab + deruxtecan) is an advanced targeted anti-cancer medicine used primarily in the treatment of HER2-positive cancers, including breast cancer and gastric cancer. It is an antibody-drug conjugate (ADC) that combines the targeted action of trastuzumab with the potent chemotherapy agent deruxtecan, delivering cancer-killing effects directly to tumor cells while minimizing damage to healthy tissues.

📞 Contact Details to Place Order

💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com

• Trastuzumab binds to HER2 receptors on cancer cells, blocking their growth signals.
• Deruxtecan, a cytotoxic agent, enters the cancer cells and destroys them from within.

This targeted approach makes Enhertu highly effective in patients who have not responded well to other HER2 therapies.

Composition and Content

• Active Ingredients:
  • Trastuzumab
  • Deruxtecan
• Form: Lyophilized powder for injection
• Strength: Typically available as 100 mg vial

How to Use

• Administered as an intravenous (IV) infusion under medical supervision
• Given in a hospital or oncology clinic setting
• Infusion duration usually lasts 30–90 minutes depending on tolerance

Dosage

• Standard recommended dose: 5.4 mg/kg body weight
• Given once every 3 weeks (21-day cycle)
• Dose adjustments may be required based on:
  • Patient condition
  • Side effects
  • Doctor’s recommendation

Uses

Enhertu is used for treating:

• HER2-positive breast cancer (metastatic or unresectable)
• HER2-low breast cancer
• Gastric or gastroesophageal junction cancer
• Other HER2-expressing solid tumors (as prescribed)

Treatments & Benefits

• Effective in patients resistant to previous HER2 therapies
• Improves survival rates and disease control
• Targeted therapy reduces widespread toxicity
• Suitable for advanced-stage cancers

Advantages

• Highly targeted drug delivery system
• Strong anti-tumor activity
• Better outcomes in heavily pretreated patients
• Reduced systemic chemotherapy exposure

Possible Side Effects

• Nausea and vomiting
• Fatigue
• Hair loss
• Decreased appetite
• Low blood counts
• Serious risk: Interstitial lung disease (requires monitoring)

Storage Conditions

• Store in a refrigerator at 2°C to 8°C
• Protect from light
• Do not freeze
• Keep in original packaging until use

Alternative Indian Brands for Enhertu

Currently, trastuzumab + deruxtecan combination (Enhertu) has limited generic availability in India due to patent protection. However, alternative HER2-targeted therapies include:

• Trastuzumab-based brands:
  • Herclon (Trastuzumab)
  • Canmab (Trastuzumab)
  • Vivitra (Trastuzumab)
• Other HER2 therapies:
  • Pertuzumab combinations
  • T-DM1 (Trastuzumab emtansine)

👉 Note: These are not direct substitutes but may be used depending on treatment plans.

Buy Enhertu (Trastuzumab + Deruxtecan) Injection Online from GlobMedIndia

Looking to buy Enhertu Injection online at the best price? GlobMedIndia is a trusted medicine exporter providing authentic anti-cancer medicines with fast and secure delivery worldwide.

Why Choose GlobMedIndia?

• ✔ Genuine and WHO-compliant medicines
• ✔ Affordable global pricing
• ✔ Safe packaging & cold-chain delivery
• ✔ 24/7 customer support
• ✔ Fast international shipping

🚀 Order Now – Fast Delivery Available

Get Enhertu trastuzumab deruxtecan injection delivered safely to your doorstep.

📞 Contact Now:
💬 WhatsApp: +91 9730316395
📞 Phone: +91 9730316395
📧 Email: info@globmedindia.com

🌍 Delivery Available Across India & Worldwide

Major Demand Cities in India:

• Mumbai
• Delhi
• Hyderabad
• Chennai
• Bangalore
• Pune
• Nagpur
• Ahmedabad

International Demand Countries:

• USA
• UK
• UAE
• Oman
• Saudi Arabia
• South Africa
• Bangladesh
• Nepal

Enhertu injection online, trastuzumab deruxtecan price India, buy Enhertu online India, HER2 breast cancer medicine, anti cancer injection exporter India, targeted cancer therapy drug, Enhertu supplier India, GlobMedIndia medicines, oncology drug exporter, HER2 positive cancer treatment

Conclusion

Enhertu (trastuzumab + deruxtecan) represents a breakthrough in targeted cancer therapy, offering hope to patients with HER2-positive cancers. With GlobMedIndia, you can order this life-saving medicine safely, affordably, and quickly anywhere in the world.